相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis
Sravan K. Payeli et al.
ARTHRITIS AND RHEUMATISM (2012)
Fibroblast Activation Protein in Remodeling Tissues
M. Jacob et al.
CURRENT MOLECULAR MEDICINE (2012)
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
Chrystal U. Louis et al.
BLOOD (2011)
Considerations for the Clinical Application of Chimeric Antigen Receptor T Cells: Observations from a Recombinant DNA Advisory Committee Symposium Held June 15, 2010
Hildegund C. J. Ertl et al.
CANCER RESEARCH (2011)
Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata
Chad E. Brokopp et al.
EUROPEAN HEART JOURNAL (2011)
Trafficking of CAR-Engineered Human T Cells Following Regional or Systemic Adoptive Transfer in SCID Beige Mice
Ana Caterina Parente-Pereira et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
CD28 Costimulation Impairs the Efficacy of a Redirected T-cell Antitumor Attack in the Presence of Regulatory T cells Which Can Be Overcome by Preventing Lck Activation
David M. Kofler et al.
MOLECULAR THERAPY (2011)
A human memory T cell subset with stem cell-like properties
Luca Gattinoni et al.
NATURE MEDICINE (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Inhibition of Fibroblast Activation Protein and Dipeptidylpeptidase 4 Increases Cartilage Invasion by Rheumatoid Arthritis Synovial Fibroblasts
Caroline Ospelt et al.
ARTHRITIS AND RHEUMATISM (2010)
Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc 'spacer' domain in the extracellular moiety of chimeric antigen receptors avoids 'off-target' activation and unintended initiation of an innate immune response
A. Hombach et al.
GENE THERAPY (2010)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency
Salima Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-α
Matthew Kraman et al.
SCIENCE (2010)
Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours
Osamu Dohi et al.
HISTOPATHOLOGY (2009)
Rational development of high-affinity T-cell receptor-like antibodies
Guillaume Stewart-Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Multimodality Strategies in Malignant Pleural Mesothelioma
Walter Weder et al.
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY (2009)
US mesothelioma patterns 1973-2002: indicators of change and insights into background rates
Mary Jane Teta et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2008)
Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma
I Opitz et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2006)
Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes
Stefan Bauer et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Supernatural T cells: Genetic modification of T cells for cancer therapy
MH Kershaw et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation
D Friedmann-Morvinski et al.
BLOOD (2005)
Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments
G Held et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Stromal antigen targeting by a humanised monoclonal antibody:: An early phase II trial of sibrotuzamab in patients with metastatic colorectal cancer
RD Hofheinz et al.
ONKOLOGIE (2003)